Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 150

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 150
---
 for IPTV. Mr. Dykan serves currently as Chairman of ReWalk Robotics and was a member of the American Institute
of Certified Public Accountants from 1982 through 2021 and holds a B.Sc. in accounting and management and an M.B.A. in computer applications,
both from New York University.

Mr. Keith Valentine, Director

Mr. Keith Valentine has served
on our Board of Directors since 2015. Mr. Valentine currently serves as President, Chief Executive Officer and as a director of SeaSpine
since 2015. Prior to joining SeaSpine, Mr. Valentine served as President and Chief Operating Officer of NuVasive, Inc., from 2007 to 2015
and as President from 2004 to 2007, prior to which he served in various senior executive roles in Marketing, Development and Operations
since joining the company in 2001. Previously, Mr. Valentine was Vice President of Marketing at ORATEC Interventions, Inc., which was
acquired by Smith & Nephew PLC, and spent eight years in various roles with Medtronic Sofamor Danek including Vice President of Marketing
for the Thoracolumbar Division and Group Director for the BMP Biologics program, the Interbody Sales Development Effort, and International
Sales and Marketing. Mr. Valentine received a B.B.A. in Management and Biomedical Sciences from Western Michigan University.

Mr. Efraim Cohen-Arazi, Director Nominee

Mr. Efraim Cohen-Araziwill
become our director at the effective time of the registration statement to which this prospectus relates. Mr. Cohen-Arazi was the
Co-Founder & Chief Executive Officer of Rainbow Medical, a leading Israeli medical device innovation house since 2008. From 2004 to
2006 Mr. Cohen-Arazi served as the Chief Executive Officer and Co-Founder of IntecPharma Ltd. and as Chairman of CollPlant Ltd. since
2006. Mr. Cohen-Arazi served as a director in numerous biotech/medtech companies since 2005, and currently serves as a director in PainReform
Ltd. (NASDAQ: PRFX). Mr. Cohen-Arazi was the Senior VP Head of Operations at Immunex Corporation in Seattle, Washington until 2002 when
it was acquired by Amgen, where he served as VP and General Manager of the TO site in California. Mr. Cohen Arazi served at Merck